Lithium Carbonate

碳酸锂

Report date: 2026/05/22 20:01:29
NME

Base Information

Drug NameLithium Carbonate
Drug Alias Name碳化锂碳酸锂盐LiskonumCamcolitLithmax +[13
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsMedullary thyroid cancer (MTC)CNS Embryonal TumorBipolar I Disorder +[25
Global Approved IndicationsSchizoaffective disorderBipolar Disorder
Approved Indications in ChinaBipolar Disorder
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesTaiwan +[10
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Active IndicationsPost-Acute COVID-19 SyndromeBipolar DisorderFractures, Bone +[7
Inactive IndicationsMedullary thyroid cancer (MTC)CNS Embryonal TumorBipolar I Disorder +[18

Other Information

ATC CodeN05AN01